Westlake Village Biopartners

Westlake Village BioPartners is a venture capital firm based in Los Angeles, specializing in life sciences and biotechnology. Founded in 2018 by Beth Seidenberg, M.D., a former general partner at Kleiner Perkins, and Sean Harper, M.D., the firm has raised a total of $1.3 billion across three funds. Their most recent fund, launched in July 2023, raised $450 million to incubate and grow early-stage biotech companies. Westlake Village BioPartners focuses on transformative human therapeutic technologies, investing in companies from their early stages through Series B rounds. Their portfolio includes notable companies such as Latigo Biotherapeutics, which is developing non-opioid pain medicines, and Kyverna Therapeutics, which recently closed an upsized initial public offering. The firm is committed to catalyzing the Los Angeles biotech hub by supporting innovative startups and leveraging their extensive network and expertise in both scientific and business realms. Their leadership team includes experienced professionals like Mira Chaurushiya, Ph.D., and David Allison, Ph.D., who bring deep scientific and venture capital experience to the table.